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Background. Helicobacter pylori chronically colonizes gastric/duodenal mucosa and induces gastroduodenal disease and vigorous
humoral and cellular immune responses. Methods. In order to clarify the immunological changes induced by this infection, we
determined the percentage and, as indicated, ratios of the following cells in peripheral blood of 45 H. pylori-infected patients and
21controlsubjects:CD4+ Tcell,CD8 + Tcells,Thelper1cells(Th1),Thelper2cells(Th2),CD4+CD25+ Tc ells,F o xp3 + regulatory
T cells (Tregs), CD4/CD8 ratio, and Th1/Th2 ratio. Results. The percentage of CD8+ T cells was signiﬁcantly lower in H. pylori-
infectedpatients(mean±SD;18.0±7.1%)comparedtocontrolsubjects(mean±SD;23.2±7.8%)(P<0.05).TheCD4/CD8ratio
was signiﬁcantly higher in H. pylori-infected patients (mean±SD; 3.1 ±2.4) compared to control subjects (mean±SD; 2.1 ±1.0)
(P<0.05). The Th1/Th2 ratio was signiﬁcantly lower in H. pylori-infected patients (mean±SD; 10.0 ± 8.5) compared to control
subjects (mean±SD; 14.5 ± 9.0) (P<0.05). The percentage of CD4+CD25+ Tc e l l si nH. pylori-infected patients (mean±SD;
13.2 ± 6.2%) was signiﬁcantly higher than that in control subjects (mean±SD; 9.8 ± 3.4%) (P<0.05). However, there was no




Helicobacter pylori is a gram-negative, highly motile, and
spiral-shaped bacterium, which is 2.5–3.5μm long and 0.5–
1.0μm in diameter and has one to six polar ﬂagella at
one end. H. pylori was discovered in intact areas of antral
mucosa of human stomach [1]. The organism colonizes the
non-acid-secreting mucosa of the stomach and the upper
intestinal tract, including the duodenum. It survives in the
acidic conditions of the stomach by generating ammonia
from urea. The ammonia is believed to neutralize gastric
acidity around the H. pylori. Person-to-person contact and
ingestion of contaminated food or water are probable
mechanisms for transmission of H. pylori [2].
Recent studies have revealed that H. pylori causes persis-
tentinfectioninthehumangastrointestinaltractandinduces
chronic gastritis, peptic ulcers, gastric cancer, and malignant
lymphoma [3–5]. Furthermore, H. pylori was reported to
induce vigorous humoral and cellular immune responses.
White blood cell, neutrophil or lymphocyte counts were
reported to increase in H. pylori-infected patients [6, 7].
Conﬂicting data were reported on the percentages of B and T
cell subsets in H.pylori-infectedpatients.Onestudyreported
no signiﬁcant change in the percentages of B cell, CD4, CD8,
or NK cell in peripheral blood lymphocytes [8, 9]. On the
other hand, Soares et al. reported increased peripheral blood
CD4, activated CD4 and CD8 cells in H. pylori-infected
patients [10].2 Gastroenterology Research and Practice
H. pylori colonization of the gastric mucosa promotes
severe local inﬂammation and induces recruitment of CD4+
and CD8+ cells [11]. Th1 cells also accumulate in the gastric
mucosa of H. pylori-infected patients and are reported to
promote mucosal inﬂammation by secretion of IFN-gamma
[12].
Regulatory T cells (Tregs) are nonproliferative and/or
anergic in response to polyclonal stimulation but can sup-
press the proliferation and cytokine production of both
CD4+ and CD8+ T cells via a cell-cell contact-dependent
mechanism [13]. Their surface marker phenotype has been
established as CD4+CD25+Foxp3+ [14]. H. pylori colonizes
gastric mucosa for an extended period despite the presence
of a host immune system. Thus, it is hypothesized that the
Tregs are involved in actively suppressing the host immune
response.Infact,thenumberofTregsingastricmucosaofH.
pylori-infected patients is signiﬁcantly higher than in healthy
controls [15–18].
In addition to gastrointestinal disease, H. pylori is associ-
ated with several autoimmune diseases, including idiopathic
thrombocytopenic purpura (ITP), Sj¨ ogren syndrome, sys-
temic sclerosis [19], Graves’ disease [20], and autoimmune
pancreatitis [21]. Given this association with autoimmune
diseases, we hypothesized that H. pylori might induce
systemic immunological changes. We, therefore, compared
the following immune characteristics in peripheral blood
of H. pylori-infected patients and control subjects: CD4+
T cells, CD8+ T cells, ratio of CD4/CD8 cells, Th1 cells,
Th2 cells, ratio of Th1/Th2 cells, CD4+CD25+ T cells, and
CD4+CD25+Foxp3+ T cells.
2. Patientsand Methods
2.1. Patients. This study was performed with approval
from the Human Research Ethical Committee of Gunma
University Hospital, and all patients and volunteers gave
informed consent. Forty-ﬁve H. pylori-infected patients (32
male, 13 female) diagnosed at Gunma University Hospital
between 2007 and 2010 were included in this study. The
median age of the patients was 58 years (range, 22–81 years),
and the male-female ratio was 32/13. Infection by H. pylori
was established by the following criteria: positive tests for
urease and/or the biopsy sample of the stomach. Controls
were obtained from 21 H. pylori-uninfected donors, who
were negative for serum anti-H. pylori IgG antibody (Eiken
Chemical Co., Ltd, Tokyo, Japan). The male/female ratio of
controls was 1.1 (11/10) and the median age was 36 years
(range, 23–65 years). The clinical data for study subjects are
shown in Table 1.
2.2. Measurement of CD4/CD8 Ratio. Peripheral blood cells
were collected using EDTA-3K. Lymphocytes were labeled
using the following monoclonal antibodies: CD45-FITC/
CD4-RD1/CD8-ECD/CD3-PC5 (Cyto-Stat tetraCHROME
monoclonal antibodies) and subsets were ana lyzed using an
EPICS XL System II (Beckman Coulter, Fullerton, CA).
2.3. Measurement of Th1/Th2 Ratio. Whole heparinized
blood was incubated at 37◦Cw i t h7 %C O 2 for 4 hours with
Table 1: Characteristics of participants in this study.
Control H. Pylori
Cases (n)2 1 4 5
Sex (male: female) (9:9) (32:13)
Age median: range (year) 36: 23–65∗ 58.0: 22–81∗
Hemoglobin (g/dl) 13.7 ±1.21 3 .8 ±1.6
Hematocrit (%) 41.4 ±4.04 1 .0 ±3.5
WBC (×109/l) 5.7 ±1.56 .3 ±1.8
Neutrophils (×109/l) 3.2 ±1.23 .8 ±1.4
Monocytes (×109/l) 0.32 ±1.10 .35 ±1.1
Lymphocytes (×109/l) 1.8 ±0.51 .8 ±0.5
Platelets (×109/l) 233.9 ±55.4 241.0 ±67.9
mean ± SD ∗P values < 0.05.
25ng/mL phorbol 12-myristate 13-acetate (Sigma-Aldrich,
S t .L o u i s ,M O ) ,1μg/mL ionomycin, and 10μg/mL Brefeldin
A (Sigma-Aldrich, St. Louis, MO).
After treatment with FACS lysing solution and FACS
permeabilizing solution (BD Biosciences, San Jose, CA),
cells were stained at 4◦C for 30min with antihuman CD4-
PE-Cy5 (BD Pharmingen, San Jose, CA), FastImmune
ﬂuorescein isothiocyanate (FITC)-labeled antihuman IFN-
γ, and phycoerythrin- (PE-) labeled antihuman IL-4 (BD
Biosciences, San Jose, CA). FastImmune IgG2a FITC/IgG1
PE isotype controls (BD Biosciences, San Jose, CA) were
used as negative controls for human IFN-γ and IL-4.
Measurement of Th subsets was performed by 3-color ﬂow
cytometry as described below for Treg cells.
2.4. Treg Cell Measurements. PE-Cy5 antihuman CD4 mon-
oclonal antibody (BD Pharmingen, San Diego, CA) and
FITC antihuman CD25 (BD Biosciences, San Jose, CA)
were used for surface antigen staining. Mouse IgG1, κ-
FITC (BD Pharmingen) was used as an isotype control. PE-
conjugated antihuman Foxp3 (PCH101) and PE-conjugated
rat IgG2a isotype control from eBiosciences (San Diego,
CA) were used for intracellular Foxp3 staining according
to the manufacturer’s instructions. Tregs were deﬁned as
CD4+CD25+Foxp3+ cells. Three-color ﬂow cytometric anal-
ysis was performed on FACS Calibur ﬂow cytometer using
Cell Quest software (BD Biosciences, San Jose, CA).
2.5. Complete Blood Cell Count. Complete blood cell counts
were performed using a total blood analyzer (ADVIA 120,
Siemens, Tarrytown, NY).
2.6. Statistical Analysis. Data analysis was performed using
SPSS statistics 17.0 (IBM, USA). Comparisons of quantita-
tive data were performed using a nonparametric test (Mann-
Whitney U test). P values < 0.05 were considered signiﬁcant.
3. Results
3.1. Patient Populations. The clinical data for study subjects
is shown in Table 1. The median age was signiﬁcantly
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Figure 1: (a) Comparison of the percentage of CD4+ and CD8+ T cells. Left and right sides show the data of control subjects and H.
pylori-infected patients, respectively. White columns represent the percentage of CD4+ T lymphocyte, and black columns represent CD8+
T lymphocyte. Data are given as mean ± SD. There was no signiﬁcant diﬀerence in the percentage of CD4+ Tc e l l si nH. pylori-infected
patients (mean ± SD; 43.0 ± 10.4%) as compared to control subjects (mean ± SD; 42.2 ± 8.1%). However, the percentage of CD8+ Tc e l l s
was signiﬁcantly lower in H. pylori-infected patients (mean ± SD; 18.0 ± 7.1%) compared to control subjects (mean ± SD; 23.2 ± 7.8%)
(P<0.05). (b) CD4/CD8 ratio in control subjects (white column) and H. pylori-infected patients (black column). Data are given as mean ±
SD. The CD4/CD8 ratio was signiﬁcantly higher in H. pylori-infected patients (mean ± SD; 3.1 ± 2.4) compared to control subjects (mean
± SD; 2.1 ±1.0) (P<0.05).
the control group. However, there were no signiﬁcant
diﬀerences between the two groups in other items. White
blood cell, neutrophil, monocyte, and lymphocyte counts
were statistically identical in H. pylori-infected patients and
control subjects.
3.2. Percentage of CD4+ TC e l l sa n dC D 8 + T Cells, and CD4/8
Ratio. Peripheral blood cells were labeled with CD4 and
CD8 tags and analyzed by FACS. We found no signiﬁcant
diﬀerence in the percentage of CD4+ Tc e l l si nH. pylori-
infected patients (mean ± SD; 43.0 ± 10.4%) as compared
t oc o n t r o ls u b j e c t s( m e a n± SD; 42.2 ± 8.1%). However,
the percentage of CD8+ T cells was signiﬁcantly lower in H.
pylori-infected patients (mean ± SD; 18.0±7.1%) compared
to control subjects (mean ± SD; 23.2 ± 7.8%) (P<0.05)
(Figure 1(a)).
Reﬂecting the decrease in percentage of CD8+ cells, the
CD4/CD8 ratio was signiﬁcantly higher in H. pylori-infected
patients (mean ± SD; 3.1±2.4) compared to control subjects
(mean ± SD; 2.1 ±1.0) (P<0.05) (Figure 1(b)).
3.3. Percentage of Th1 and Th2 Cells, and Th1/Th2 Ratio.
Peripheral blood cells were stained for FACS analysis with
markers for CD4 as well as intracellular stains for IFN-γ and
IL-4 to identify Th1 and Th2 cells, respectively. There was
no signiﬁcant diﬀerence in the percentage of Th1 cells in
H. pylori-infected patients (mean ± SD; 20.2 ± 8.6%) and
c o n t r o ls u b j e c t s( m e a n± SD; 21.2 ± 10.6%). However, the
percentage of Th2 cells in H. pylori-infected patients (mean
± SD; 2.8 ± 1.6%) was signiﬁcantly higher than in control
subjects (mean ± SD; 1.8 ± 1.0%), (P<0.05) (Figure 2(a)).
Consistent with the increase in Th2 cells, the Th1/Th2 ratio
was signiﬁcantly lower in H. pylori-infected patients (mean
± SD; 10.0±8.5) compared to control subjects (mean ± SD;
14.5 ±9.0) (P<0.05) (Figure 2(b)).
3.4. Percentage CD4+CD25+ and CD4+CD25+Foxp3+ TC e l l s .
The percentage of CD4+CD25+ Tc e l l si nH. pylori-infected
patients (mean ± SD; 13.2 ± 6.2%) was signiﬁcantly higher
than that in control subjects (mean ± SD; 9.8 ± 3.4%)
(P<0.05) (Figure 3). This cell population includes both
activated CD4+ T cells and Tregs and thus changes in Tregs
could be masked in this impure population. To measure the
percentages of the Tregs, we monitored the frequency of
CD4+CD25+Foxp3+ T cells. The percentage of these Tregs
was not signiﬁcantly diﬀerent between H. pylori-infected
patients(mean ±SD;4.1±2.1%)andcontrolsubjects(mean
± SD; 4.0 ±1.7%) (Figure 3).
3.5. The Diﬀerence of T Lymphocyte Subsets between Young
and Old Subjects in the Control Group. Because the mean
age of the control subjects was lower than that of the patient
group, the control subjects were divided into 2 groups: <40
years old (n = 13) and ≥40 years old (n = 8). When
comparing the mean percentage of T lymphocyte subsets,
there were no signiﬁcant diﬀerences between the <40 group
and the ≥40 group (Table 2).
4. Discussion
Infection of the gastric mucosa with H. pylori is thought
to occur in early childhood and to play a key role in the
pathogenesis of many gastroduodenal diseases, including
gastric ulcers, duodenal ulcers, gastric cancer, and gastric
lymphoma. Previous studies have shown that H. pylori




































































Figure 2: (a) The percentage of Th1 cells and Th2 cells. Left and right ﬁgures show the percentage of Th1 and Th2 cells, respectively.
White columns represent the data of normal subjects, and black columns represent the data of H. pylori-infected patients. Data are given as
mean ± SD. There was no signiﬁcant diﬀerence in the percentage of Th1 cells in H. pylori-infected patients (mean ± SD; 20.2 ± 8.6%) and
control subjects (mean ± SD; 21.2 ± 10.6%). However, the percentage of Th2 cells in H. pylori-infected patients (mean ± SD; 2.8 ± 1.6%)
was signiﬁcantly higher than in control subjects (mean ± SD; 1.8 ± 1.0%), (P<0.05). (b) Comparison of Th1/Th2 ratio. White columns
represent the data of normal subjects, and black columns represent the data of H. pylori-infected patients. Data are given as mean ± SD.
The Th1/Th2 ratio was signiﬁcantly lower in H. pylori-infected patients (mean ± SD; 10.0 ±8.5) compared to control subjects (mean ± SD;
14.5 ±9.0) (P<0.05).
responses. Kondo et al. reported that patients with H.
pylori infection had increased neutrophile and monocyte
counts in their peripheral blood [6]. Karttunen et al. also
reported that white blood cell and lymphocyte counts were
increased in H. pylori-infected patients [7]. In contrast, in
our report, we found no signiﬁcant diﬀerence in white blood
cell, neutrophil, lymphocyte, and monocyte counts between
H. pylori-infected patients and control subjects. Because H.
pylori-infection induces chronic and local inﬂammation in
gastric mucosa, it might not inﬂuence the absolute blood cell
counts.
Yuceyar et al. reported no signiﬁcant diﬀerence between
H. pylori-infected patients and normal subjects in the
peripheral lymphocyte proﬁle, including T-, B-, CD4+ T-,
CD8+ T- and NK cells [9]. Conversely, the data presented
here, show a decrease in the percentage of CD8+ T cells and
an increase in the CD4/CD8 ratio in peripheral blood cells
of H. pylori-infected patients. CD8+ T cells have also been
reported to accumulate in the gastric mucosa and participate
in the inﬂammatory process, promoting the severity of the
disease[22,23].Thesestudiescorroboratetheﬁndingsofour
study which suggests that the distribution of CD8+ Tc e l l s
changes in H. pylori-infected patients, with peripheral CD8+
T cells migrating into the gastric mucosa.
It is well known that H. pylori induces T-cell polarization
towards a Th1-dominant response in gastric mucosa [24].
Moreover, D’Elios showed that H. pylori-speciﬁc Th1 cells
could be cloned from H. pylori-infected gastric mucosa
and that these cells were cytotoxic to gastric epithelial cells
as they produced IFN-γ [12]. However, few reports have
been published to date characterizing the Th1/Th2 ratio
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Figure 3: The percentage of CD4+CD25+ T cell and CD4+
CD25+Foxp3+ (regulatory T cell). Left and right sides show the
data of control subjects and H. pylori-infected patients, respectively.
White columns represent the percentage of CD4+CD25+ Tc e l l ,a n d
black columns represent the percentage of regulatory T cell. Data
aregivenasmean ±SD.ThepercentageofCD4+CD25+ TcellsinH.
pylori-infected patients (mean ± SD; 13.2±6.2%) was signiﬁcantly
higher than that in control subjects (mean ± SD; 9.8 ± 3.4%) (P<
0.05).ThepercentageofTregs(CD4+CD25+Foxp3+ Tcells)wasnot
signiﬁcantly diﬀerent between H. pylori-infected patients (mean ±
SD; 4.1 ±2.1%) and control subjects (mean ± SD; 4.0 ±1.7%).
Table 2: The diﬀerence of T-lymphocyte subsets between young
and old subjects in control group.
Age < 40 Age ≥ 40 P values
Cases (n)1 3 8
CD4 T cells (%) 43.2 ± 7.3 40.7 ± 9.4 0.89
CD8 T cells (%) 22.4 ± 3.9 24.4 ± 12.1 0.59
CD4/CD8 ratio 2.0 ± 0.4 2.3 ± 1.6 0.89
Th1 cells (%) 19.1 ± 10.1 24.6 ± 11.3 0.096
Th2 cells (%) 1.7 ± 0.8 2.0 ± 1.2 0.66
Th1/Th2 ratio 14.0 ± 9.0 15.2 ± 9.6 0.83
CD4+CD25+ T cells (%) 9.7 ± 3.6 10.0 ± 3.4 0.66
CD4+CD25+Foxp3+ T
cells (%) 3.9 ± 1.8 4.3 ± 1.5 0.66
that the Th1/Th2 ratio in peripheral blood is signiﬁcantly
decreased in H. pylori-infected patients as compared to nor-
mal subjects. We hypothesize that, as suggested for the CD8+
T cells, peripheral blood Th1 cells migrate to the gastric
mucosa in H. pylori-infected patients.
Age-related diﬀerence in Tregs has been described con-
troversially [25]. Rosenkranz et al. reported that the fre-
quency of Tregs (CD4+Foxp3+) increased with aging [26],
and Gregg et al. also reported an increase in peripheral blood
CD4+CD25 high regulatory T cells associated with aging
[27]. Conversely, others reported no correlation between the
numberofcirculatingCD4+CD25highTregsandage[28].In
our study, we found that there was no statistical diﬀerence in
the mean number of Tregs between <40-year-old and >40-
year-old control subjects. Therefore, it was considered that
the diﬀerence of age between control group and the patient
group did not aﬀect the evaluation of Tregs in H. pylori-
infected patients.
There was no report about the number/ratio of periph-
eral CD4+CD25+Foxp3+ Tregs in H. pylori-infected patients.
Lundgren et al. reported that H. pylori-infected patients
have an impaired memory CD4+ Tc e l lr e s p o n s et oH.
pylori that is linked to the presence of H. pylori-speciﬁc
CD4+25+ T cells in peripheral blood, which actively suppress
the response [29]. These authors also demonstrated the
presence of Tregs that expressed the characteristic CD4+25+
surface markers and coexpressed high levels of Foxp3 mRNA
in the gastric mucosa [15]. In the data reported here the
percentage of peripheral blood CD4+CD25+ T cells, but
not CD4+25+Foxp3+ T cells, increased in H. pylori-infected
patients. Since CD4+CD25+ Tc e l l si n c l u d eT r e g sa sw e l la s
activated T cells, our data indicate that the percentage of
Tregs did not increase in the peripheral blood of H. pylori-
infected patients.
Tregs did not decrease, but the activation of humoral
immunity and Th2 polarization were observed in the
peripheralbloodofH.pylori-infectedpatients.Insomecases,
these changes may induce systemic autoimmune diseases.
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